AsiaTIDES: Oligonucleotide and Peptide Therapeutics | Tokyo, Japan

Start Date : February 26, 2019
End Date : February 28, 2019
Time : 9:00 am to5:00 pm

Email : Allison.MacDonald@knect365.com

Location :
Hilton Tokyo Bay, 1-8 Maihama, Urayasu-shi, 279-0031, Japan

Website

Get Direction View Large Map

Description

Register your team today and join 300 scientists and executives at our upcoming meeting, held February 26 - 28, 2019 in Tokyo.


AsiaTIDES 2019 keynote presentation lineup:


1) The Discovery of Semaglutide – A Journey from Ala Scan to Structural Design of GLP-1 Analogues
- Jesper Lau, PhD.,Vice President, Protein and Peptide Chemistry at Novo Nordisk A/S


2) New Strategies and Technologies in Oligonucleotide Therapeutic Development
- Thazha P. Prakash, PhD.,Director, Medicinal Chemistry at Ionis Pharmaceuticals


3) The Chemistry behind Approved Oligonucleotide Therapeutics
- Muthiah (Mano) Manoharan, PhD., Senior Vice President of Drug Discovery at Alnylam Pharmaceuticals, Inc.


4) From Stereopurity to Precision Medicine: Optimizing the Properties of Antisense Nucleic Acid Therapeutics
- Chandra Vargeese, PhD., SVP, Head of Drug Discovery at WAVE Life Sciences


Brochurehttps://go.evvnt.com/355503-3?pid=3506 


Prices:
Conference Pass + Pre-Conference Workshop: USD 3023.0,
Conference Pass: USD 2375.0


 


Speakers: Jesper Lau, PhD., Novo Dordisk A/S, Thazha P. Prakash, Ph.D., Ionis Pharmaceuticals , Muthiah (Mano) Manoharan, PhD., Alnylam Pharmaceuticals, Inc, Chandra Vargeese, PhD., WAVE Life Sciences


Category: Conferences | Education

Organized by

Organized by LoveEvvnt1

KNect365 Life Sciences

Email: Allison.MacDonald@knect365.com


Event Categories: Health & Nutrition.




Your Review

You must be logged in to post a comment.